Not all clients with CLL have to have therapy. In spite of all latest advances, the iwCLL even now suggests watchful observation for individuals with asymptomatic disease.86 This suggestion relies on no less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).ddb… Read More